TY - CHAP
T1 - Investigation of Single Nucleotide Polymorphisms Associated to Familial Combined Hyperlipidemia with Random Forests
AU - Staiano, Antonino
AU - di Taranto, Maria Donata
AU - Bloise, Elena
AU - D'Agostino, Maria Nicoletta
AU - D'Angelo, Antonietta
AU - Marotta, Gennaro
AU - Gentile, Marco
AU - Jossa, Fabrizio
AU - Iannuzzi, Arcangelo
AU - Rubba, Paolo
AU - Fortunato, Giuliana
PY - 2013
Y1 - 2013
N2 - Single nucleotide polymorphisms (SNPs) are the foremost part of many genome association studies. Selecting a subset of SNPs that is sufficiently informative but still small enough to reduce the genotyping overhead is an important step towards disease-gene association. In this work, a Random Forest (RF) approach to informative SNPs selection in Familial Combined Hyperlipidemia (FCH) is proposed. FCH is the most common form of familial hyperlipidemia. Affected patients have elevated levels of plasma triglycerides and/or total cholesterol and show increased risk of premature coronary heart disease. In order to identify susceptibility markers for FCH we perform the analysis of 21 SNPs in ten genes associated with high cardiovascular risk. RF appears to be a useful technique in identifying gene polymorphisms involved in FCH: the identified SNPs confirmed some variants in a couple of genes as genetic markers of FCH as proved in various studies in scientific literature and lead us to report for the first time a further gene association with FCH. This result could be promising and encourages to further investigate on the role of the identified gene in the development of FCH phenotype.
AB - Single nucleotide polymorphisms (SNPs) are the foremost part of many genome association studies. Selecting a subset of SNPs that is sufficiently informative but still small enough to reduce the genotyping overhead is an important step towards disease-gene association. In this work, a Random Forest (RF) approach to informative SNPs selection in Familial Combined Hyperlipidemia (FCH) is proposed. FCH is the most common form of familial hyperlipidemia. Affected patients have elevated levels of plasma triglycerides and/or total cholesterol and show increased risk of premature coronary heart disease. In order to identify susceptibility markers for FCH we perform the analysis of 21 SNPs in ten genes associated with high cardiovascular risk. RF appears to be a useful technique in identifying gene polymorphisms involved in FCH: the identified SNPs confirmed some variants in a couple of genes as genetic markers of FCH as proved in various studies in scientific literature and lead us to report for the first time a further gene association with FCH. This result could be promising and encourages to further investigate on the role of the identified gene in the development of FCH phenotype.
KW - Familial combined hyperlipidemia
KW - Feature selection
KW - Genome association
KW - Machine learning
KW - Random forests
KW - Single nucleotide polymorphisms
UR - http://www.scopus.com/inward/record.url?scp=84879316641&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84879316641&partnerID=8YFLogxK
U2 - 10.1007/978-3-642-35467-0_18
DO - 10.1007/978-3-642-35467-0_18
M3 - Chapter
AN - SCOPUS:84879316641
SN - 9783642354663
VL - 19
T3 - Smart Innovation, Systems and Technologies
SP - 169
EP - 178
BT - Smart Innovation, Systems and Technologies
ER -